Fiscal Receipts

Medical Development

NRDT&EPartial Reconciliation0604771N
What it is
Medical Development — a research & development program run by Navy.
What changed
-$742.0K FY25→26
Who gets it
No award linkage at high confidence.

Budget Figures

FY24 Actuals
$17.5M
FY25 Total
$8.37M
FY26 Request
$7.63M
FY25→26 Change
-$742.0K

FY2026 award data is a partial year — USASpending awards are reported on a rolling basis and the fiscal year does not close until September 30. why partial FY2026 data? →

Budget Trajectory
FY24: $17.5MFY25: $8.37MFY26: $7.63MFY24FY25FY26
FY24
$17.5M
FY25
$8.37M
FY26
$7.63M
Decade view — each figure cites its own President's Budget edition
FY2015 actuals — PB2017 editionFY2016 actuals — PB2018 editionFY2017 actuals — PB2019 editionFY2018 actuals — PB2020 editionFY2019 actuals — PB2021 editionFY2020 actuals — PB2022 editionFY2021 actuals — PB2023 editionFY2022 actuals — PB2024 editionFY2023 actuals — PB2025 editionFY2024 actuals — PB2026 editionFY2016 enacted — PB2017 editionFY2017 enacted — PB2018 editionFY2018 enacted — PB2019 editionFY2019 enacted — PB2020 editionFY2020 enacted — PB2021 editionFY2021 enacted — PB2022 editionFY2022 enacted — PB2023 editionFY2023 enacted — PB2024 editionFY2024 enacted — PB2025 editionFY2025 enacted — PB2026 editionFY2017 request — PB2017 editionFY2018 request — PB2018 editionFY2019 request — PB2019 editionFY2020 request — PB2020 editionFY2021 request — PB2021 editionFY2022 request — PB2022 editionFY2023 request — PB2023 editionFY2024 request — PB2024 editionFY2025 request — PB2025 editionFY2026 request — PB2026 editionFY15FY26

● actuals (line)  ·  ○ enacted  ·  ◇ request — gaps are editions the program is absent from, never interpolated.

SeriesFY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Actuals$26.6M$24.7M$24.5M$36.4M$36.8M$32.0M$38.3M$30.4M$15.6M$17.5M
Enacted$25.3M$9.22M$9.35M$38.1M$33.2M$39.6M$31.5M$16.2M$6.06M$8.37M
Request$9.22M$9.35M$8.10M$8.18M$2.12M$3.97M$3.18M$6.06M$8.37M$7.63M

blank = series not published for this year; – = absent from that edition.

Asked vs spent: the PB2021 book requested $2.12M for FY2021; the PB2023 book reports $38.3M actually spent — $36.1M above the request.

Program Lineage

No predecessor/successor lineage was recorded for this program element — no FY-to-FY transfer into or out of this line was stated in the ingested J-books, and none was inferred from the program structure.

Description

Mission — Congressional Adds

Congressional Adds

Mission — Medical/Dental Equipment Dev

The purpose of this program is to develop biomedical equipment and related techniques to reduce morbidity; to enhance the logistic feasibility of modern medical care for combat casualties; to sustain casualties for evacuation to fixed medical facilities for definitive care; and to ensure that personnel are medically qualified for military duty. Each work unit undertaken in this project has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects. The purpose of this program is to develop, test, and evaluate expeditionary medical systems and equipment to save warfighter lives, facilitate movement of patients up the roles of care, and return warfighters to the fight, especially in the Distributed Maritime environment. Each work unit undertaken in this program has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firms/industry participation in the projects.

Mission — Medical Development

The purpose of this program is to develop biomedical equipment and related techniques to reduce morbidity; to enhance the logistic feasibility of modern medical care for combat casualties; to sustain casualties for evacuation to fixed medical facilities for definitive care; and to ensure that personnel are medically qualified for military duty. Each work unit undertaken in this project has a military requirement. Efforts are justified based upon military payoff and cost benefit. There is a strong potential for dual use, technology transfer, and biotechnology firm/industry participation in the projects.

Justification

No accomplishments or planned-program narratives in this line's J-book detail — some exhibits carry figures without per-project prose.

Budget Line Items(workbook-cited)

Exhibit R-1

AccountOrgTypeAmount
Research, Development, Test and Evaluation, NavyNFY24 Actuals$17.5M
Research, Development, Test and Evaluation, NavyNFY25 Enacted$8.37M
Research, Development, Test and Evaluation, NavyNFY25 Total$8.37M
Research, Development, Test and Evaluation, NavyNFY26 Disc. Request$7.63M
Research, Development, Test and Evaluation, NavyNFY26 Total$7.63M

Budget Details(R-2/P-40 facts)

ProjectAll Prior YearsFY24 ActualsFY25 TotalFY26 BaseFY26 Request
9999: Congressional Adds$0$11.6M$0$0$0
Program Element$25.7M$17.5M$8.37M$7.63M$7.63M
0933: Medical/Dental Equipment Dev$25.7M$5.89M$8.37M$7.63M$7.63M

No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 17 of 1741 programs). why coverage is partial? →

Awards

No awards are linked to this program element at high confidence — the budget→award crosswalk only asserts links it can defend, and this line has none yet.

Lobbying Mentions

No Senate LDA lobbying filing in the tracked data mentions this program element by code or alias.

Oversight

GAO oversight: DOD — 5 high-risk areas

No research dossier for this program — dossiers cover 50 of 1741 programs, the largest fully J-book-detailed lines by FY2026 requested dollars. why no dossier here? →

Primary Sources